These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Nuclear receptors and coregulators in inflammation and cancer. Lee JS; Kim KI; Baek SH Cancer Lett; 2008 Aug; 267(2):189-96. PubMed ID: 18433989 [TBL] [Abstract][Full Text] [Related]
26. Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Moreau A; Vilarem MJ; Maurel P; Pascussi JM Mol Pharm; 2008; 5(1):35-41. PubMed ID: 18159929 [TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptors as therapeutic targets in inflammation. Plutzky J J Am Coll Cardiol; 2003 Nov; 42(10):1764-6. PubMed ID: 14642685 [No Abstract] [Full Text] [Related]
28. Alternative splicing determines the interaction of SMRT isoforms with nuclear receptor-DNA complexes. Faist F; Short S; Kneale GG; Sharpe CR Biosci Rep; 2009 Jun; 29(3):143-9. PubMed ID: 18752469 [TBL] [Abstract][Full Text] [Related]
29. ERK5 is involved in TCR-induced apoptosis through the modification of Nur77. Fujii Y; Matsuda S; Takayama G; Koyasu S Genes Cells; 2008 May; 13(5):411-9. PubMed ID: 18429814 [TBL] [Abstract][Full Text] [Related]
30. Narrowing in on cardiovascular disease: the atheroprotective role of peroxisome proliferator-activated receptor gamma. Gerry JM; Pascual G Trends Cardiovasc Med; 2008 Feb; 18(2):39-44. PubMed ID: 18308193 [TBL] [Abstract][Full Text] [Related]
31. FXR: a metabolic regulator and cell protector. Wang YD; Chen WD; Moore DD; Huang W Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165 [TBL] [Abstract][Full Text] [Related]
32. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases. van Neerven S; Kampmann E; Mey J Prog Neurobiol; 2008 Aug; 85(4):433-51. PubMed ID: 18554773 [TBL] [Abstract][Full Text] [Related]
33. Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity. Pols TW; Ottenhoff R; Vos M; Levels JH; Quax PH; Meijers JC; Pannekoek H; Groen AK; de Vries CJ Biochem Biophys Res Commun; 2008 Feb; 366(4):910-6. PubMed ID: 18086558 [TBL] [Abstract][Full Text] [Related]
34. PPARs as Key Mediators in the Regulation of Metabolism and Inflammation. Vázquez-Carrera M; Wahli W Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563416 [TBL] [Abstract][Full Text] [Related]
36. [Influence of rosiglitazone on the airway inflammation in guinea pigs with asthma]. Bao ZJ; Xiang XD; Deng JW Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):424-6, 436. PubMed ID: 14653138 [No Abstract] [Full Text] [Related]
37. Peroxisome proliferator-activated receptor-gamma ligands: a pluripotent class of pharmacological agents that may prove to be useful for adjuvant treatment of sepsis and multiple organ dysfunction syndrome. Fink MP Crit Care Med; 2004 Feb; 32(2):604-5. PubMed ID: 14758194 [No Abstract] [Full Text] [Related]
38. Look who's talking: nuclear receptors in the liver and gastrointestinal tract. Downes M; Liddle C Cell Metab; 2008 Mar; 7(3):195-9. PubMed ID: 18316024 [TBL] [Abstract][Full Text] [Related]
39. Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms. Pesce M; Esposito G; Sarnelli G Curr Opin Pharmacol; 2018 Dec; 43():81-86. PubMed ID: 30218940 [TBL] [Abstract][Full Text] [Related]
40. [Peroxisome poliferator-activated receptors and their modulators]. Cai ZF; Guo ZR Yao Xue Xue Bao; 2004 Feb; 39(2):158-60. PubMed ID: 15127628 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]